Ultrastructural definition of apoptosis in heart failure

Eloisa Arbustini1, Agnese Brega, Jagat Narula

  • 1Centro Malattie Genetiche Cardiovascolari, Fondazione IRCCS, Policlinico San Matteo, Pavia, Italy. e.arbustini@smatteo.pv.it

Heart Failure Reviews
|January 4, 2008
PubMed

Insights

Cardiac myocytes undergo apoptosis, oncosis, and autophagy. These cell death pathways, particularly apoptosis and autophagy, are observed in failing human hearts, suggesting potential shared therapeutic targets for preserving myocyte integrity.

Area of Science:

  • Cardiovascular Biology
  • Cellular Pathology

Background:

  • Cardiac myocytes exhibit multiple cell death pathways, including apoptosis, oncosis, and autophagy.
  • Understanding these mechanisms is crucial for addressing heart failure.
  • Apoptosis involves nuclear fragmentation and apoptotic bodies, with clearance by macrophages without inflammation.

Purpose of the Study:

  • To describe the morphological characteristics of cardiac myocyte death.
  • To investigate the prevalence and significance of apoptosis, oncosis, and autophagy in failing human hearts.
  • To explore potential shared therapeutic strategies for preserving myocyte integrity.

Main Methods:

  • Light and electron microscopy to visualize morphological changes.
  • Immunoelectron microscopy for detailed analysis of apoptotic markers (cytochrome c, TUNEL, annexin V).
  • Observation of myocyte death features in human decompensated hearts.

Main Results:

  • Apoptosis is characterized by nuclear fragmentation and apoptotic bodies, cleared without inflammation.
  • Oncosis presents distinct morphological features and can coexist with apoptosis, especially in ischemic conditions.
  • Autophagy, a defense mechanism, can lead to necrosis if lysosomal removal is impaired.
  • While late-stage apoptosis and autophagy are rare in failing hearts, early apoptotic and autophagic changes are present in viable myocytes across various etiologies.

Conclusions:

  • Morphological features of apoptosis, oncosis, and autophagy can coexist in cardiac myocytes.
  • Early signs of apoptosis and autophagy are detectable in viable myocytes of failing human hearts, irrespective of etiology.
  • The shared pathways of myocyte death suggest that therapeutic strategies targeting these mechanisms could preserve myocyte integrity in heart failure.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...